Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
A phosphodiesterase inhibitor is a drug that blocks one or more of the five subtypes of the enzyme phosphodiesterase (PDE), thereby preventing the inactivation of the intracellular second messengers cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) by the respective PDE subtype(s).
PDE inhibitor drugs are also used to treat various other medical conditions such as autoimmune indications, ulcerative colitis, and others. However, the increasing incidence of ED across the world will boost the global phosphodiesterase inhibitors market growth during the forecast period.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Phosphodiesterase (PDE) inhibitors market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Phosphodiesterase (PDE) inhibitors market. Detailed analysis of key players, along with key growth strategies adopted by Phosphodiesterase (PDE) inhibitors industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
GlaxoSmithKline Plc
Vivus Inc
Pfizer Inc
Eli Lilly and Co
Bayer AG
By Type:
PDE1 Selective Inhibitors
PDE2 Selective Inhibitors
PDE3 Selective Inhibitors
PDE4 selective inhibitors
PDE5 selective inhibitors
PDE7 selective inhibitors
PDE10 selective inhibitors
By End-User:
Oral
Topical
Other
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Phosphodiesterase (PDE) inhibitors Market
-
1.3 Market Segment by Type
-
1.3.1 USA Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE1 Selective Inhibitors from 2016 to 2027
-
1.3.2 USA Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE2 Selective Inhibitors from 2016 to 2027
-
1.3.3 USA Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE3 Selective Inhibitors from 2016 to 2027
-
1.3.4 USA Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE4 selective inhibitors from 2016 to 2027
-
1.3.5 USA Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE5 selective inhibitors from 2016 to 2027
-
1.3.6 USA Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE7 selective inhibitors from 2016 to 2027
-
1.3.7 USA Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE10 selective inhibitors from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of Oral from 2016 to 2027
-
1.4.2 USA Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of Topical from 2016 to 2027
-
1.4.3 USA Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Phosphodiesterase (PDE) inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Phosphodiesterase (PDE) inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Phosphodiesterase (PDE) inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Phosphodiesterase (PDE) inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Phosphodiesterase (PDE) inhibitors Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Phosphodiesterase (PDE) inhibitors by Major Types
-
3.4.1 Market Size and Growth Rate of PDE1 Selective Inhibitors
-
3.4.2 Market Size and Growth Rate of PDE2 Selective Inhibitors
-
3.4.3 Market Size and Growth Rate of PDE3 Selective Inhibitors
-
3.4.4 Market Size and Growth Rate of PDE4 selective inhibitors
-
3.4.5 Market Size and Growth Rate of PDE5 selective inhibitors
-
3.4.6 Market Size and Growth Rate of PDE7 selective inhibitors
-
3.4.7 Market Size and Growth Rate of PDE10 selective inhibitors
4 Segmentation of Phosphodiesterase (PDE) inhibitors Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Phosphodiesterase (PDE) inhibitors by Major End-Users
-
4.4.1 Market Size and Growth Rate of Phosphodiesterase (PDE) inhibitors in Oral
-
4.4.2 Market Size and Growth Rate of Phosphodiesterase (PDE) inhibitors in Topical
-
4.4.3 Market Size and Growth Rate of Phosphodiesterase (PDE) inhibitors in Other
5 Market Analysis by Regions
-
5.1 USA Phosphodiesterase (PDE) inhibitors Production Analysis by Regions
-
5.2 USA Phosphodiesterase (PDE) inhibitors Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Phosphodiesterase (PDE) inhibitors Landscape Analysis
-
6.1 West USA Phosphodiesterase (PDE) inhibitors Landscape Analysis by Major Types
-
6.2 West USA Phosphodiesterase (PDE) inhibitors Landscape Analysis by Major End-Users
7 South USA Phosphodiesterase (PDE) inhibitors Landscape Analysis
-
7.1 South USA Phosphodiesterase (PDE) inhibitors Landscape Analysis by Major Types
-
7.2 South USA Phosphodiesterase (PDE) inhibitors Landscape Analysis by Major End-Users
8 Middle West USA Phosphodiesterase (PDE) inhibitors Landscape Analysis
-
8.1 Middle West USA Phosphodiesterase (PDE) inhibitors Landscape Analysis by Major Types
-
8.2 Middle West USA Phosphodiesterase (PDE) inhibitors Landscape Analysis by Major End-Users
9 Northeast USA Phosphodiesterase (PDE) inhibitors Landscape Analysis
-
9.1 Northeast USA Phosphodiesterase (PDE) inhibitors Landscape Analysis by Major Types
-
9.2 Northeast USA Phosphodiesterase (PDE) inhibitors Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 GlaxoSmithKline Plc
-
10.1.1 GlaxoSmithKline Plc Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Vivus Inc
-
10.2.1 Vivus Inc Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Pfizer Inc
-
10.3.1 Pfizer Inc Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Eli Lilly and Co
-
10.4.1 Eli Lilly and Co Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Bayer AG
-
10.5.1 Bayer AG Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE1 Selective Inhibitors from 2016 to 2027
-
Figure USA Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE2 Selective Inhibitors from 2016 to 2027
-
Figure USA Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE3 Selective Inhibitors from 2016 to 2027
-
Figure USA Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE4 selective inhibitors from 2016 to 2027
-
Figure USA Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE5 selective inhibitors from 2016 to 2027
-
Figure USA Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE7 selective inhibitors from 2016 to 2027
-
Figure USA Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE10 selective inhibitors from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of Oral from 2016 to 2027
-
Figure USA Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of Topical from 2016 to 2027
-
Figure USA Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Phosphodiesterase (PDE) inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Phosphodiesterase (PDE) inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Phosphodiesterase (PDE) inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Phosphodiesterase (PDE) inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Phosphodiesterase (PDE) inhibitors Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Phosphodiesterase (PDE) inhibitors
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Phosphodiesterase (PDE) inhibitors by Different Types from 2016 to 2027
-
Table Consumption Share of Phosphodiesterase (PDE) inhibitors by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of PDE1 Selective Inhibitors
-
Figure Market Size and Growth Rate of PDE2 Selective Inhibitors
-
Figure Market Size and Growth Rate of PDE3 Selective Inhibitors
-
Figure Market Size and Growth Rate of PDE4 selective inhibitors
-
Figure Market Size and Growth Rate of PDE5 selective inhibitors
-
Figure Market Size and Growth Rate of PDE7 selective inhibitors
-
Figure Market Size and Growth Rate of PDE10 selective inhibitors
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Phosphodiesterase (PDE) inhibitors by Different End-Users from 2016 to 2027
-
Table Consumption Share of Phosphodiesterase (PDE) inhibitors by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Oral
-
Figure Market Size and Growth Rate of Topical
-
Figure Market Size and Growth Rate of Other
-
Table USA Phosphodiesterase (PDE) inhibitors Production by Regions
-
Table USA Phosphodiesterase (PDE) inhibitors Production Share by Regions
-
Figure USA Phosphodiesterase (PDE) inhibitors Production Share by Regions in 2016
-
Figure USA Phosphodiesterase (PDE) inhibitors Production Share by Regions in 2021
-
Figure USA Phosphodiesterase (PDE) inhibitors Production Share by Regions in 2027
-
Table USA Phosphodiesterase (PDE) inhibitors Consumption by Regions
-
Table USA Phosphodiesterase (PDE) inhibitors Consumption Share by Regions
-
Figure USA Phosphodiesterase (PDE) inhibitors Consumption Share by Regions in 2016
-
Figure USA Phosphodiesterase (PDE) inhibitors Consumption Share by Regions in 2021
-
Figure USA Phosphodiesterase (PDE) inhibitors Consumption Share by Regions in 2027
-
Table West USA Phosphodiesterase (PDE) inhibitors Consumption by Types from 2016 to 2027
-
Table West USA Phosphodiesterase (PDE) inhibitors Consumption Share by Types from 2016 to 2027
-
Figure West USA Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2016
-
Figure West USA Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2021
-
Figure West USA Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2027
-
Table West USA Phosphodiesterase (PDE) inhibitors Consumption by End-Users from 2016 to 2027
-
Table West USA Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2016
-
Figure West USA Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2021
-
Figure West USA Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2027
-
Table South USA Phosphodiesterase (PDE) inhibitors Consumption by Types from 2016 to 2027
-
Table South USA Phosphodiesterase (PDE) inhibitors Consumption Share by Types from 2016 to 2027
-
Figure South USA Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2016
-
Figure South USA Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2021
-
Figure South USA Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2027
-
Table South USA Phosphodiesterase (PDE) inhibitors Consumption by End-Users from 2016 to 2027
-
Table South USA Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2016
-
Figure South USA Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2021
-
Figure South USA Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2027
-
Table Middle West USA Phosphodiesterase (PDE) inhibitors Consumption by Types from 2016 to 2027
-
Table Middle West USA Phosphodiesterase (PDE) inhibitors Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2016
-
Figure Middle West USA Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2021
-
Figure Middle West USA Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2027
-
Table Middle West USA Phosphodiesterase (PDE) inhibitors Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2016
-
Figure Middle West USA Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2021
-
Figure Middle West USA Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2027
-
Table Northeast USA Phosphodiesterase (PDE) inhibitors Consumption by Types from 2016 to 2027
-
Table Northeast USA Phosphodiesterase (PDE) inhibitors Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2016
-
Figure Northeast USA Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2021
-
Figure Northeast USA Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2027
-
Table Northeast USA Phosphodiesterase (PDE) inhibitors Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2016
-
Figure Northeast USA Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2021
-
Figure Northeast USA Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of GlaxoSmithKline Plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc
-
Table Product and Service Introduction of GlaxoSmithKline Plc
-
Table Company Profile and Development Status of Vivus Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vivus Inc
-
Figure Sales and Growth Rate Analysis of Vivus Inc
-
Figure Revenue and Market Share Analysis of Vivus Inc
-
Table Product and Service Introduction of Vivus Inc
-
Table Company Profile and Development Status of Pfizer Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc
-
Figure Sales and Growth Rate Analysis of Pfizer Inc
-
Figure Revenue and Market Share Analysis of Pfizer Inc
-
Table Product and Service Introduction of Pfizer Inc
-
Table Company Profile and Development Status of Eli Lilly and Co
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Co
-
Figure Sales and Growth Rate Analysis of Eli Lilly and Co
-
Figure Revenue and Market Share Analysis of Eli Lilly and Co
-
Table Product and Service Introduction of Eli Lilly and Co
-
Table Company Profile and Development Status of Bayer AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG
-
Figure Sales and Growth Rate Analysis of Bayer AG
-
Figure Revenue and Market Share Analysis of Bayer AG
-
Table Product and Service Introduction of Bayer AG
-
